Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hermes

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Protein Science : a Publication of the Protein Society|October 1, 1995
Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzymeJ W Becker, A I Marcy, L L Rokosz, et al.
Journal of Biomolecular Screening|October 23, 2014
Use of high-throughput mass spectrometry to reduce false positives in protease uHTS screensGregory C Adam, Juncai Meng, Joseph M Rizzo, et al.
SLAS Discovery : Advancing Life Sciences R & D|April 21, 2017
High-Throughput Agonist Shift Assay Development for the Analysis of M<sub>1</sub>-Positive Allosteric ModulatorsMichelle F Homsher, Douglas C Beshore, Jason Cassaday, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2009
Disubstituted pyrimidines as Lck inhibitorsJulianne A Hunt, Richard T Beresis, Joung L Goulet, et al.
ACS Chemical Biology|December 30, 2016
Iterative Focused Screening with Biological Fingerprints Identifies Selective Asc-1 Inhibitors Distinct from Traditional High Throughput ScreeningPeter S Kutchukian, Lee Warren, Brian C Magliaro, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2005
The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infectionYusheng Xiong, Judyann Wiltsie, Andrea Woods, et al.
Nature Communications|August 4, 2018
Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathyR Fledrich, T Abdelaal, L Rasch, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 25, 2005
Anthrax lethal factor inhibitionW L Shoop, Y Xiong, J Wiltsie, et al.
ACS Chemical Biology|February 4, 2021
NanoClick: A High Throughput, Target-Agnostic Peptide Cell Permeability AssayAndrea Peier, Lan Ge, Nicolas Boyer, et al.
Nature|May 20, 2006
Platensimycin is a selective FabF inhibitor with potent antibiotic propertiesJun Wang, Stephen M Soisson, Katherine Young, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Protein Science : a Publication of the Protein Society|October 1, 1995
Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzymeJ W Becker, A I Marcy, L L Rokosz, et al.
Journal of Biomolecular Screening|October 23, 2014
Use of high-throughput mass spectrometry to reduce false positives in protease uHTS screensGregory C Adam, Juncai Meng, Joseph M Rizzo, et al.
SLAS Discovery : Advancing Life Sciences R & D|April 21, 2017
High-Throughput Agonist Shift Assay Development for the Analysis of M<sub>1</sub>-Positive Allosteric ModulatorsMichelle F Homsher, Douglas C Beshore, Jason Cassaday, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2009
Disubstituted pyrimidines as Lck inhibitorsJulianne A Hunt, Richard T Beresis, Joung L Goulet, et al.
ACS Chemical Biology|December 30, 2016
Iterative Focused Screening with Biological Fingerprints Identifies Selective Asc-1 Inhibitors Distinct from Traditional High Throughput ScreeningPeter S Kutchukian, Lee Warren, Brian C Magliaro, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2005
The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infectionYusheng Xiong, Judyann Wiltsie, Andrea Woods, et al.
Nature Communications|August 4, 2018
Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathyR Fledrich, T Abdelaal, L Rasch, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 25, 2005
Anthrax lethal factor inhibitionW L Shoop, Y Xiong, J Wiltsie, et al.
ACS Chemical Biology|February 4, 2021
NanoClick: A High Throughput, Target-Agnostic Peptide Cell Permeability AssayAndrea Peier, Lan Ge, Nicolas Boyer, et al.
Nature|May 20, 2006
Platensimycin is a selective FabF inhibitor with potent antibiotic propertiesJun Wang, Stephen M Soisson, Katherine Young, et al.
Pageof 8